Distillate Capital Partners LLC lessened its position in Amdocs Limited (NASDAQ:DOX - Free Report) by 6.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 170,575 shares of the technology company's stock after selling 11,109 shares during the period. Distillate Capital Partners LLC owned approximately 0.15% of Amdocs worth $14,523,000 at the end of the most recent reporting period.
Several other large investors also recently made changes to their positions in the company. Sterling Capital Management LLC grew its holdings in Amdocs by 52.7% during the fourth quarter. Sterling Capital Management LLC now owns 6,670 shares of the technology company's stock worth $568,000 after acquiring an additional 2,302 shares during the period. Scotia Capital Inc. boosted its position in shares of Amdocs by 22.7% in the fourth quarter. Scotia Capital Inc. now owns 3,942 shares of the technology company's stock worth $336,000 after buying an additional 729 shares during the period. APG Asset Management N.V. purchased a new position in Amdocs during the 4th quarter valued at about $4,876,000. Renaissance Technologies LLC increased its stake in Amdocs by 97.6% in the 4th quarter. Renaissance Technologies LLC now owns 134,400 shares of the technology company's stock valued at $11,443,000 after buying an additional 66,400 shares during the period. Finally, Bank of Montreal Can raised its holdings in shares of Amdocs by 2.2% during the fourth quarter. Bank of Montreal Can now owns 210,450 shares of the technology company's stock worth $17,918,000 after acquiring an additional 4,569 shares in the last quarter. Institutional investors and hedge funds own 92.02% of the company's stock.
Amdocs Stock Performance
Amdocs stock traded up $0.45 during mid-day trading on Tuesday, reaching $84.55. The company had a trading volume of 573,619 shares, compared to its average volume of 701,146. The company has a quick ratio of 1.20, a current ratio of 1.16 and a debt-to-equity ratio of 0.22. The firm has a market cap of $9.54 billion, a price-to-earnings ratio of 19.62, a PEG ratio of 1.47 and a beta of 0.59. The company has a 50 day moving average of $87.57 and a 200-day moving average of $87.22. Amdocs Limited has a 52 week low of $74.41 and a 52 week high of $93.34.
Amdocs (NASDAQ:DOX - Get Free Report) last released its earnings results on Tuesday, February 4th. The technology company reported $1.45 earnings per share for the quarter, missing the consensus estimate of $1.64 by ($0.19). Amdocs had a net margin of 10.19% and a return on equity of 18.89%. On average, sell-side analysts expect that Amdocs Limited will post 6.21 EPS for the current fiscal year.
Amdocs Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Monday, March 31st will be paid a $0.527 dividend. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.49%. This is a positive change from Amdocs's previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Monday, March 31st. Amdocs's dividend payout ratio is presently 48.72%.
Wall Street Analysts Forecast Growth
Separately, StockNews.com downgraded shares of Amdocs from a "strong-buy" rating to a "buy" rating in a research report on Friday, February 28th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $101.20.
Check Out Our Latest Analysis on Amdocs
About Amdocs
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Further Reading

Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.